Management tracks: Fountain Medical taps Zhen as CEO; plus DBV, Momenta reveal CFO succession plans

Fountain Medical Development Ltd. named Ling Zhen as CEO and co-chairman. Zhen joins the clinical CRO from Draper Dragon Venture Group, where he was a partner focused on biopharmaceutical and medical technology investments. Zhen is a veteran of IQVia Holdings Inc. (NYSE:IQV), Eli Lilly and Co. (NYSE:LLY) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).

Food allergy company DBV Technologies S.A. (NASDAQ:DBVT) hired Ramzi Benamar as CFO, effective Jan. 6. Benamar was VP and head of financial planning and analysis at gene therapy company Spark Therapeutics Inc. DBV Chief of Staff Sébastien Robitaille had been interim CFO since August following the departure of principal financial officer David Schilansky...